| Condition (No. of Subjects) |
|
Pregnancy, %
|
|
| Treatment |
Treatment Group |
Placebo Group |
Reference |
|
| Abnormal spermatozoa and failure of IVF (77) |
Testosterone undecanoate |
17 |
32 |
Comhaire et al, 1995 |
| Azoospermia caused by hypogonadotropic hypogonadism (25) |
hCG and FSH |
67 |
— |
Bakircioglu et al, 2007 |
| Oligoasthenoteratozoospermia (18) |
hMG |
— |
— |
Beretta et al, 2005 |
| Oligoasthenoteratozoospermia (23) |
R-hFSH, 150 IU for 3 months |
30 |
0/10 |
Caroppo et al, 2003b |
| Oligoasthenozoospermia (24) |
FSH |
33 |
20 |
Baccetti et al, 2004 |
| Severe oligozoospermia (78) |
pFSH (75 IU FSH, <1 IU LH) for  50 days |
36 |
18 |
Ashkenazi et al, 1999 |
| Idiopathic, severe oligoteratoasthenospermia (76) |
pFSH |
33 |
— |
Dirnfeld et al, 2000 |
| Oligoteratoasthenozoospermia (40) |
FSH |
20 |
— |
Ben-Rafael et al, 2000 |
|
| Abbreviations: FSH, follicle-stimulating hormone; hCG, human chorionic
gonadotropin; hMG, human menopausal gonadotropin; ICSI, intracytoplasmic sperm
injection; IVF, in vitro fertilization; LH, luteinizing hormone; pFSH,
purified FSH; R-hFSH, recombinant human FSH. |
|